 Shares of Mesa Laboratories NASDAQ:MLAB were unchanged after the company reported Q4 results.Quarterly Results Earnings per share decreased 26.29 over the past year to 1.29, which beat the estimate of 0.21.Revenue of 34,208,000 up by 29.35 from the same period last year, which missed the estimate of 34,430,000.Outlook Earnings guidance hasnt been issued by the company for now.View more earnings on MLABMesa Laboratories hasnt issued any revenue guidance for the time being.Recent Stock Performance 52-week high: 271.46Companys 52-week low was at 181.21Price action over last quarter: Up 6.17Company Profile Mesa Laboratories Inc provides control products and services. Its Instruments division manufactures quality-control instruments and disposable products for the pharmaceutical, food and beverage, medical device, industrial hygiene, air sampling, and semiconductor industries. The Sterilization and disinfection control division provides testing services, as well as biological and chemical indicators used to assess the efficacy of sterilization and disinfection processes. The Cold chain monitoring division designs, develops and markets systems used to monitor environmental parameters, such as temperature and humidity. The Cold chain packaging division monitors the parameters of products in a cold chain and provides packaging development consulting services and thermal packaging products.See more from Benzinga Recap: Thermon Group Q4 Earnings Sterling Bancorp: Q1 Earnings Insights 16 Consumer Cyclical Stocks Moving In Mondays Pre-Market SessionC 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved. 